Search clinical trials for: Placebo to match asenapine

Total 1441 results

Northwell Health
Solace Brands, Inc.

Withdrawn

The Use of Cannabinoid Patch for Knee Osteoarthritis

Osteoarthritis | Knee Osteoarthritis | CBD

United States
Gilead Sciences

Terminated

Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting

COVID-19

United States, Spain, Denmark, United Kingdom
Novartis Pharmaceuticals

Completed

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Alzheimer Disease

United States, Germany, Italy, Spain, France, Canada, Switzerland
GlaxoSmithKline

Completed

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Czechia
Organon and Co

Completed

A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

Schizophrenia
Hisamitsu Pharmaceutical Co., Inc.

Completed

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

Ankle Sprain

United States
Noven Pharmaceuticals, Inc.

Completed

Irritation and Sensitization Study of HP-5000 Topical System

Osteoarthritis of the Knee

United States
Organon and Co
Meiji Seika Pharma Co., Ltd.

Completed

Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)

Schizophrenia
Unity Health Toronto
Schering-Plough

Completed

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

Agitation

United States
Genzyme, a Sanofi Company

Terminated

ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial (ZACFAST)

Breast Cancer

Italy
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
Organon and Co

Completed

40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)

Bipolar Disorder
University of Cincinnati
Merck Sharp & Dohme LLC; University of Louisville

Terminated

Asenapine for Bipolar Depression

Bipolar Depression

United States
GlaxoSmithKline

Completed

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, United States, Netherlands, Czechia
Merck Sharp & Dohme LLC

Completed

Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)

Dementia
Theracos

Completed

Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus Type 2

United States, Canada
Mayo Clinic
Pfizer

Completed

The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation (ATTAC)

Inflammation | Atrial Fibrillation | Arrhythmia | Endothelial Dysfunction

United States
Gilead Sciences
Galapagos NV

Completed

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment (FINCH 2)

Rheumatoid Arthritis

United States, France, Germany, Spain, Israel, Japan, Korea, Republic of, Belgium, Argentina, Poland, Hungary, United Kingdom, Mexico, Australia, Switzerland
AstraZeneca

Completed

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Alzheimer's Disease

Peru, Poland, Canada, South Africa
National Institute of Allergy and Infectious Diseases...
International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Withdrawn

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

HIV Infections
Panion & BF Biotech Inc.

Completed

Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

Solar Lentigines

Taiwan
Organon and Co

Completed

12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)

Bipolar Disorder
Izun Pharma Ltd

Suspended

Herbal Periodontal Patch (THPP) for Gingival Inflammation in Diabetics

Gingival Inflammation in Diabetic Patients

Israel
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States, Canada, Australia
Agile Therapeutics

Completed

Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

Contraception

United States
Organon and Co

Completed

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

Hypertension
Gilead Sciences
AstraZeneca

Terminated

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

Heart Failure, Congestive

United States
Laguna Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm (COR-ART)

Atrial Flutter | Symptomatic Atrial Fibrillation

Israel, Russian Federation
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Australia
Forest Laboratories

Completed

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Schizophrenia

United States
Noema Pharma AG

Recruiting

Basimglurant in Children, Adolescents, and Young Adults With TSC

Tuberous Sclerosis Complex

United States, Turkey, Poland, Spain, United Kingdom, India, Italy, Israel
Alyatec

Completed

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Allergic Rhinitis | Rhinoconjunctivitis | Allergy to Pollen

France
Merck Sharp & Dohme LLC

Completed

Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)

Healthy Volunteers
Pharmacyclics LLC.
Janssen Research & Development, LLC

Completed

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)

Mantle-Cell Lymphoma

France, Canada, Spain, United States, Hungary, Korea, Republic of, Greece, Australia, Netherlands, Belgium, United Kingdom, Czechia, Germany, Poland, Italy, Turkey, Ukraine
Vanderbilt University Medical Center
National Institute of Mental Health (NIMH)

Recruiting

Depressed Mood Improvement Through Nicotine Dosing 3 (DepMIND3)

Depressive Disorder

United States
Organon and Co

Completed

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)

Schizophrenia
Frontier Biotechnologies Inc.

Completed

Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects

Chronic Low Back Pain

China
Cytokinetics

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM (MAPLE-HCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

United States, Denmark, Spain, Netherlands, United Kingdom, Germany, France, China, Israel, Italy, Hungary, Canada, Brazil
Organon and Co

Completed

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)

Schizophrenia
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa

Spain, France, United States, Austria, Germany, Hungary, Belgium, Iceland, Netherlands, Denmark, Czechia
Henry Ford Health System

Active, not recruiting

Optimizing Phototesting and Investigating Photobiology of Visible Light

Healthy

United States
Forest Hills Lab

Not yet recruiting

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

Parkinson Disease
nCap Medical
University of Pittsburgh

Not yet recruiting

NEUROCUPLE™ in TKA Patients

Total Knee Arthroplasty

United States
Organon and Co

Completed

Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)

Bipolar 1 Disorder
Gilead Sciences
Galapagos NV

Terminated

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis (HUMBOLDT)

Noninfectious Uveitis

United States, Israel, United Kingdom, Germany, Australia, Canada, New Zealand
GlaxoSmithKline
Labtec GmbH

Completed

An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode

Herpes Labialis

Germany
GlaxoSmithKline

Withdrawn

Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica

Polymyalgia Rheumatica
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)

Plaque Psoriasis
Kallyope Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

Obesity

United States
ReveraGen BioPharma, Inc.
Santhera Pharmaceuticals

Recruiting

A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)

Becker Muscular Dystrophy

United States, Italy

3

Subscribe